FindTrial
Sign In

Study on Nervous System in Patients with COVID-19 by Using multimodal MRI

Study on Nervous System in Patients with COVID-19 by Using multimodal MRI

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071002
Enrollment
Unknown
Registered
2023-04-28
Start date
2022-12-28
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

COVID group:NA
Healthy control:NA

Sponsors

The People's Hospital of Guangxi Zhuang Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Novel coronavirus infection or recovery after COVID-19 infection; (2) age> 18 years, gender, education background; (3) abnormal memory and cognitive function, or abnormal sleep, tinnitus, smell and smell after COVID-19 infection. However, there were no above abnormal symptoms before infection.(4) no neurological or psychiatric disease, no serious systemic disease, no drug abuse, no history of serious brain trauma or craniocerebral surgery; (5) no contraindication of magnetic resonance resonance examination.

Exclusion criteria

Exclusion criteria: (1) History of severe neurological or psychiatric diseases, systemic diseases, drug abuse, severe craniocerebral trauma or craniocerebral surgery; (2) There are contraindications to MRI.

Design outcomes

Primary

MeasureTime frame
Brain imaging indicators;Blood indicators;Neuropsychological scale;—

Countries

China

Contacts

Public ContactDemao Deng

The People's Hospital of Guangxi Zhuang Autonomous Region

demaodeng@163.com+86 13507880885

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026